(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/buy_a_domain.png

Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more

www.crwedomains.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






Latest News Releases From The Newsroom

Tahoe Resources Introduces Dividend Reinvestment Plan

August 11th, 2016

VANCOUVER, British Columbia / CRWE PRESS RELEASE / August 11, 2016 – Tahoe Resources Inc. (“Tahoe” or the “Company”) (TSX, THO; NYSE: TAHO) is pleased to announce the introduction of a dividend reinvestment plan (the &ld. Read more

National Beverage Corp. Previews First Quarter FY2017 Reaffirms Strong Momentum

August 10th, 2016

FORT LAUDERDALE, FL / CRWE PRESS RELEASE / August 10, 2016 - In response to the recent volume and volatility in its common stock trading, National Beverage Corp. (NASDAQ: FIZZ) today released comments from a recent internal meeting with Chairman and . Read more

Taseko Expands Land Package at Gibraltar

August 09th, 2016

Vancouver, BC / CRWE PRESS RELEASE / August 9, 2016 – Taseko Mines Limited (TSX: TKO; NYSE MKT: TGB) (“Taseko” or the “Company”) is pleased to announce that it has acquired new mineral claims which are adjacent to existi. Read more

Pluristem's Phase III Critical Limb Ischemia Study Wins $8 Million Grant from Europe's Horizon 2020 Program

August 09th, 2016

- The study will enroll about 250 patients in Europe and the U.S. - The grant will cover a significant portion of the study expenses - PLX-PAD was previously selected by the EMA to be developed via the Adaptive Pathways project HAIFA, ISRAE. Read more

Proposed Sale of Terex MHPS Business to Konecranes Receives European Commission and U.S. Antitrust Clearances

August 08th, 2016

WESTPORT, CT / CRWE PRESS RELEASE / August 8, 2016 - Terex Corporation (NYSE: TEX) today announced that the proposed transactions for the sale of Terex’s Material Handling & Port Solutions business to Konecranes have received European. Read more

Walmart Agrees to Acquire Jet.com, One of the Fastest Growing e-Commerce Companies in the U.S.

August 08th, 2016

Deal Positions Walmart for Expanded e-Commerce Growth and Customer Reach BENTONVILLE, Ark. and HOBOKEN, N.J. / CRWE PRESS RELEASE / August 8, 2016 – Wal-Mart Stores, Inc. and Jet.com, Inc. today announced they have entered into a definitive . Read more

Diana Shipping Inc. Announces Time Charter Contract for m/v Ismene with Glencore

August 08th, 2016

ATHENS, GREECE / CRWE PRESS RELEASE / August 8, 2016 – Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate whol. Read more

Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study

August 03rd, 2016

Rancho Cordova, Calif. / CRWE PRESS RELEASE / August 03, 2016 - Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced 40-month follow-up results for a number of patients that particip. Read more

GW Pharmaceuticals to Report Q3 Financial Results and Host Conference Call on 9 August, 2016

August 03rd, 2016

London, UK / CRWE PRESS RELEASE / Aug. 02, 2016 - GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel thera. Read more

Pluristem Receives Positive Feedback from FDA and Gears Up for Phase III Trial of PLX-PAD in Critical Limb Ischemia

August 02nd, 2016

- CLI is a severe unmet medical need whose treatment addresses a $12 billion global market - Multinational study to be conducted in U.S. and Europe - Estimated trial enrollment of approximately 250 patients - Primary endpoint for BLA will be time . Read more